TETRAMAB
associated with 4 other trademarks
Multitarget, multiepitope, multivalent centralized antibody molecule structure used to incorporate multiple target antigen binders into a single antib...

Words that describe this trademark:

Serial Number:

98559594

Mark:

TETRAMAB

Status:

New Application-Record initialized not assigned to examiner

Status Date:

05-20-2024

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Multitarget, multiepitope, multivalent centralized antibody molecule structure used to incorporate multiple target antigen binders into a single antibody, namely, multi-specific reagent antibodies for medical diagnosis purposes Printed educational and informational publications related to cancer, immunological, inflammatory and neurological disorders, namely, pamphlets, newsletters, guides Multitarget, multiepitope, multivalent centralized antibody molecule structure used to incorporate multiple target antigen binders into a single antibody, namely, multi-specific therapeutic antibodies for scientific and medical research Providing healthcare information regarding the treatment of cancer, immunological, inflammatory and neurological disorders; Providing healthcare information regarding drugs for the treatment of cancer, immunological, inflammatory and neurological disorders Providing prescription drug research information relating to drugs for the diagnosis and treatment of cancer, immunological, inflammatory and neurological disorders

Mark Description:

N/A

Class:

Medical services

Type of Mark:

Trademark

Published for Opposition Date:

N/A

Mark Drawing Status:

4

Abandon Date:

N/A

Business Name:

212 CARNEGIE CENTER, SUITE 400

Recent Trademark filings by this company